Cancer Statistics in I.R. Iran in 2020
Abstract
#No Abstract
1.Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2018). Global Can¬cer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco. iarc.fr/today. accessed 4/02/2021.
2.Zendehdel K. Cancer statistics in IR Iran in 2018. Basic & Clinical Cancer Research. 2019 Jan 2;11(1):1-4.
3.Mohebbi E, Nahvijou A, Hadji M, Rashidian H, Seyyed¬salehi MS, Nemati S, Rouhollahi MR, Zendehdel K. Iran Cancer Statistics in 2012 and Projection of Cancer Incidence by 2035. Basic & Clinical Cancer Research, 2017; 9(3): 3-22
4.Zendehdel K, Sedighi Z, Hassanloo J, Nahvijou A. Audit of A Nationwide Pathology-based Cancer Registry in Iran. Basic Clin Cancer Res. 2011 Oct 9;3(2):7-13
5.Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, Khoshaabi M, Sadjadi A, Davanlou M, Tavangar SM, et al. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry. Cancer epidemiology. 2019 Aug 1;61:50-8.
6.Roshandel Gh., Ferlay J. , Ghanbari-Motlagh A.,. Mohammadi G., Khoshaabi M., Sadjadi A., Davanlou M., Asgari F., Partovipour E., Salavati F., et al. Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int. J. Cancer. 2021;1–12 DOI: 10.1002/ijc.33574
7.Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and Water-Pipe Use in Iran: Geo¬graphical Distribution and Time Trends among the Adult Population; A Pooled Analysis of National STEPS Surveys, 2006-2009. Archives of Iranian Medicine (AIM). 2017 May 1;20(5).
8.Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, Yoonessi A, Tavangar M, Abedi BA, Sotoudehmanesh R, Pourshams A, Asgari AA, Doulatshahi S, Alizadeh BZ, Arshi S, Madjidpoor A, Mir Moomen S, Fleischer DE. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004 Jan;57(1):37-42.
9.Akbari M, Naghibzadeh-Tahami A, Khanjani N, Baneshi MR, Kamali E, Hesampour M, Nazemzadegan B, Haghdoost AA. Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran. Arch Iran Med. 2015 Sep;18(9):567-71.
2.Zendehdel K. Cancer statistics in IR Iran in 2018. Basic & Clinical Cancer Research. 2019 Jan 2;11(1):1-4.
3.Mohebbi E, Nahvijou A, Hadji M, Rashidian H, Seyyed¬salehi MS, Nemati S, Rouhollahi MR, Zendehdel K. Iran Cancer Statistics in 2012 and Projection of Cancer Incidence by 2035. Basic & Clinical Cancer Research, 2017; 9(3): 3-22
4.Zendehdel K, Sedighi Z, Hassanloo J, Nahvijou A. Audit of A Nationwide Pathology-based Cancer Registry in Iran. Basic Clin Cancer Res. 2011 Oct 9;3(2):7-13
5.Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, Khoshaabi M, Sadjadi A, Davanlou M, Tavangar SM, et al. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry. Cancer epidemiology. 2019 Aug 1;61:50-8.
6.Roshandel Gh., Ferlay J. , Ghanbari-Motlagh A.,. Mohammadi G., Khoshaabi M., Sadjadi A., Davanlou M., Asgari F., Partovipour E., Salavati F., et al. Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int. J. Cancer. 2021;1–12 DOI: 10.1002/ijc.33574
7.Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and Water-Pipe Use in Iran: Geo¬graphical Distribution and Time Trends among the Adult Population; A Pooled Analysis of National STEPS Surveys, 2006-2009. Archives of Iranian Medicine (AIM). 2017 May 1;20(5).
8.Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, Yoonessi A, Tavangar M, Abedi BA, Sotoudehmanesh R, Pourshams A, Asgari AA, Doulatshahi S, Alizadeh BZ, Arshi S, Madjidpoor A, Mir Moomen S, Fleischer DE. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004 Jan;57(1):37-42.
9.Akbari M, Naghibzadeh-Tahami A, Khanjani N, Baneshi MR, Kamali E, Hesampour M, Nazemzadegan B, Haghdoost AA. Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran. Arch Iran Med. 2015 Sep;18(9):567-71.
| Files | ||
| Issue | Vol 12 No 4 (2020) | |
| Section | Editorials | |
| DOI | https://doi.org/10.18502/bccr.v12i4.7985 | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Zendehdel K. Cancer Statistics in I.R. Iran in 2020. Basic Clin Cancer Res. 2021;12(4):159-165.
